Phospholipase, proteinase, esterase and haemolytic activity of Candida species isolated from oral cavity and its antifungal susceptibility pattern

Authors

  • Aparna T. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India https://orcid.org/0009-0003-4999-347X
  • Hashmy M. Raphy Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India https://orcid.org/0009-0008-7525-4570
  • Harish Kumar K. S. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India https://orcid.org/0000-0002-0504-7794
  • Innu S. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232085

Keywords:

Antifungal susceptibility, Candida species, Esterase, Haemolysin, Hydrolytic enzymes, Phospholipase, Proteinase

Abstract

Background: Candida species is a normal commensal flora of human body inhabiting the skin, mucous membrane and gastro intestinal tract but may be associated with superficial and deep-seated fungal infections. The switch of Candida species from commensal to a potent pathogen, is facilitated by various extracellular hydrolytic enzymes. The aim of this study was to estimate the phospholipase, proteinase, haemolysin and esterase activity of Candida species and to determine the antifungal susceptibility.

Methods: Total 100 isolates of Candida spp. were collected from diagnostic microbiology laboratories in central Kerala. Phospholipase, proteinase, esterase and haemolytic activity was determined by early defined methods of Price et al, Aoki et al, Walter Rudek and Manns et al, respectively.

Results: C. tropicalis exhibited highest phospholipase, proteinase and esterase activity followed by C. albicans and C. krusei. C.albicans shows highest haemolytic activity followed by C. tropicalis and C. krusei.

Conclusions: Extracellular enzymes, phospholipase, proteinase, esterase and haemolysin was detected among Candida species in the present study.

References

Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 2006;43(Supplement 1): S3-S14.

Sivapathasundaram B, Gururaj N. Mycotic infections of the oral cavity. In: Rajendran R, Sivapathasundaram B, eds. Shafer's Textbook of Oral Pathology. 6th ed. India: Elsevier; 2009: 363-7.

Akpan A, Morgan R. Oral candidiasis: a review. Postgrad Med J. 2002;78:455-9.

Sitheeque MAM, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (Candidal leukoplakia). Crit Rev Oral Biol Med. 2003;14:253-67.

Gozalbo D, Roig P, Villamón E, Gil ML. Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy. Curr Drug Targets-Infect Dis. 2004;4(2):117-35.

Deorukhkar SC, Roushani S. Virulence traits contributing to pathogenicity of Candida species. J. Microbiol. Exp. 2017;5:00140.

Cutler JE. Putative virulence factors of Candida albicans. Annual Microbiol. 1991;45(1):187-218.

Odds FC: Chronic mucocutaneous candidiosis. In: Candida and Candidosis. A review and bibliography 2nd ed. Bailliere Tindall, London, UK; 1988: 104-10.

Ruechel R. Virulence factors of Candida species. In: Samaranayake LP, MacFarlane TW, eds. Oral candidosis. London, United Kingdom: Wright; 1990: 47-65.

Fallon K, Bausch K, Noonan J, Huguenel E, Tamburini P. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Imm. 1997;65(2):551-6.

Polak A. Virulence of Candida albicans mutants. Mycoses. . 1992;35:9-16.

Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabour J Med Veter Mycol. 1982;20(1):7-14.

Aoki S, Ito-Kuwa S, Nakamura Y, Masuhara T. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zentralblatt Bakteriol. 1990;273(3):332-43.

Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994;62(11):5154-6.

Rudek W. Esterase activity in Candida species. J Clin Microbiol. 1978;8(6):756-9.

Clinical and Laboratory Standards Institute. M44 – method for antifungal disk diffusion susceptibility testing of yeasts, 3rd edition, 2018. Available at: https://clsi.org/media/2634/m44ed3_sample.pdf. Accessed on 20 December 2022.

Banno Y, Yamada T, Nozawa Y. Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. Sabour J Med Vet Mycol. 1985;23(1):47-54.

Lerner CG, Goldman RC. Stimuli that induce production of Candida albicans extracellular aspartyl proteinase. Microbio. 1993;139(7):1643-51.

Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol. 1996;7(1):55-69.

De Bernardis F, Mondello F, San Millàn R, Pontòn J, Cassone A. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol. 1999;37(11):3481-6.

Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Euro J Clin Microbiol Infect Dis. 1992;11:287-91.

Perfect JR. Fungal virulence genes as targets for antifungal chemotherapy. Antim Ag Chemoth. 1996;40(7):1577-83.

Jacobsen ID, Wilson D, Wächtler B, Brunke S, Naglik JR, Hube B. Candida albicans dimorphism as a therapeutic target. Exp Revi Anti-Infect Ther. 2012;10(1):85-93.

Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol. 2007;56(Pt 10):1393-8.

Deorukhkar SC, Saini S, Mathew S. Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile. Int J Microbiol. 2014;2014:456878.

Thangam M, Smitha S, Deivanayagam CN. Phospholipase activity of Candida isolates from patients with chronic lung disease. Lung India. 1989;7(3):125-6.

Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Saboura J Med Veter Mycol. 1984;22(3):201-7.

Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol. 2007;56(10):1393-8.

Luo G, Samaranayake LP, Cheung BP, Tang G. Reverse transcriptase polymerase chain reaction (RT‐PCR) detection of HLP gene expression in Candida glabrata and its possible role in in vitro haemolysin production. Apmis. 2004;112(4‐5):283-90.

Aktas E, Yigit N, Ayyildiz A. Esterase activity in various Candida species. J Int Med Res. 2002;30(3):322-4.

Downloads

Published

2023-06-30

How to Cite

T., A., Raphy, H. M., Kumar K. S., H., & S., I. (2023). Phospholipase, proteinase, esterase and haemolytic activity of Candida species isolated from oral cavity and its antifungal susceptibility pattern. International Journal of Research in Medical Sciences, 11(7), 2476–2482. https://doi.org/10.18203/2320-6012.ijrms20232085

Issue

Section

Original Research Articles